Clinical trial Recruiting at 1 site Observational Ages 18 and up

Observational study on spontaneous coronary artery dissection

Official title: Canadian Spontaneous Coronary Artery Dissection (SCAD) Study and Genetic Sub-study (Prospective, Observational Registry With 10 Year Follow-up)

Run by Cardiology Research UBC · NCT04906356 · Data updated 2026-11-12

This study is trying to learn more about spontaneous coronary artery dissection (SCAD) by following 3,000 patients over 10 years to better understand who it affects and how to treat it.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorCardiology Research UBC
Academic / other
Locations1 site (Vancouver, British Columbia)
StatusRecruiting
StartedDecember 1, 2018
Main results expectedDecember 1, 2033
Study endsDecember 1, 2033
Registry record updatedMay 28, 2021
Trial IDNCT04906356 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients admitted with acute coronary syndrome who have documented SCAD on a coronary angiogram.

Probably not a fit

Patients whose SCAD is attributed to atherosclerotic coronary artery disease will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Canadian SCAD Study is a multicenter, prospective observational registry aimed at understanding the natural history of spontaneous coronary artery dissection (SCAD) and its associated conditions. This study will enroll 3,000 patients over a 10-year follow-up period, focusing on the demographics, predisposing factors, and treatment strategies for SCAD. By collecting data from major cardiac centers across Canada and internationally, the study seeks to address the gaps in knowledge regarding SCAD, which often affects young women and is frequently misdiagnosed. The findings will help inform future randomized controlled trials and improve management strategies for SCAD patients.

Why it matters

Potential benefit: If successful, this study could lead to better diagnosis and management strategies for patients suffering from SCAD.

How similar studies have gone: While SCAD has been under-researched, this study builds on previous efforts and aims to fill significant knowledge gaps, making it a novel approach in this area.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients admitted with ACS (STEMI, NSTEMI or unstable angina)
2. Documented SCAD on a coronary angiogram (including diagnosis with OCT or IVUS)

Exclusion Criteria:

1\. Patients where SCAD is attributed to atherosclerotic coronary artery disease, with atherosclerotic coronary artery disease stenosis ≥50%

Where it's running

  • Vancouver General Hospital
    Vancouver, British Columbia, Canada
    Recruiting

Study contacts

  • Principal investigator: Jacqueline Saw, MD — Cardiology Research UBC / Vancouver General Hospital
  • Study coordinator: Andrew Starovoytov, MD
  • Email: a.starovoytov@ubc.ca
  • Phone: 6048755079

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.